Inhibitors of alpha l beta 2 mediated cell adhesion

Details for Australian Patent Application No. 2001253538 (hide)

Owner Tanabe Seiyaku Co., Ltd.

Inventors Furth, Paul S; Smith, Nicholas; Xie, Yun Feng; Sircar, Ila

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001253538

PCT Pub. Number WO01/92253

Priority 60/207,968 31.05.00 US

Filing date 17 April 2001

Wipo publication date 11 December 2001

Acceptance publication date 4 March 2004

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 031/4166

Event Publications

4 March 2004 Application Accepted

  Published as AU-B-2001253538

1 July 2004 Standard Patent Sealed

12 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253539-Methods of use of penicillamines for the treatment of conditions resulting from DNA damage

2001253537